Literature DB >> 31898186

Human Milk Oligosaccharide 2'-Fucosyllactose Reduces Neurodegeneration in Stroke Brain.

Kou-Jen Wu1, Yun-Hsiang Chen2, Eun-Kyung Bae1, YoungHa Song3, WonKi Min4, Seong-Jin Yu5.   

Abstract

2'-Fucosyllactose (2'-FL) is a major oligosaccharide in human milk and is present at trace levels in cow milk. 2'-FL reduces inflammation in the gastrointestinal tract. Its action in the central nervous system has not been well characterized. The purpose of this study is to determine 2'-FL-mediated neural protection and repair in culture and stroke brain. In rat primary cortical neuronal cultures, 2'-FL significantly antagonized N-methyl-D-aspartate (NMDA) or glutamate-mediated changes in ATP production, MAP2 immunoreactivity, and TUNEL. The influx of Ca++ (Ca++i) was examined in primary cortical neurons expressing GCaMP5, an endogenous calcium probe. NMDA increased Ca++i; 2'-FL significantly attenuated this reaction. In a rat middle cerebral artery occlusion model of stroke, we found that intracerebroventricular pretreatment or oral posttreatment with 2'-FL significantly reduced brain infarction, mitigated microglial activation, improved locomotor activity, and upregulated brain-derived neurotrophic factor (BDNF) expression. Post-stroke delivery of 2'-FL increased bromodeoxyuridine (BrdU) labeling in the perilesioned area. These BrdU cells co-expressed NeuN, or nestin, or GFAP. Using subventricular Matrigel cultures, we demonstrated that 2'-FL increased cell migration from subventricular zone explant. This response was reduced by anti-BDNF blocking antibody. In conclusion, our data suggest that 2'-FL has neuroprotective action through inhibition of Ca++i, inflammation, and apoptosis. Posttreatment with 2'-FL facilitates neural repair in stroke brain.

Entities:  

Keywords:  2′-Fucosyllactose; Human milk; Inflammation; Neuroprotection; Stroke

Mesh:

Substances:

Year:  2020        PMID: 31898186     DOI: 10.1007/s12975-019-00774-z

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.800


  42 in total

1.  Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-01-03       Impact factor: 29.690

2.  Annotation and structural elucidation of bovine milk oligosaccharides and determination of novel fucosylated structures.

Authors:  Danielle L Aldredge; Maria R Geronimo; Serenus Hua; Charles C Nwosu; Carlito B Lebrilla; Daniela Barile
Journal:  Glycobiology       Date:  2013-02-22       Impact factor: 4.313

3.  Oropharyngeal colostrum administration in extremely premature infants: an RCT.

Authors:  Juyoung Lee; Han-Suk Kim; Young Hwa Jung; Ka Young Choi; Seung Han Shin; Ee-Kyung Kim; Jung-Hwan Choi
Journal:  Pediatrics       Date:  2015-02       Impact factor: 7.124

4.  Method for milk oligosaccharide profiling by 2-aminobenzamide labeling and hydrophilic interaction chromatography.

Authors:  Karina Mariño; Jonathan A Lane; Jodie L Abrahams; Weston B Struwe; David J Harvey; Mariarosaria Marotta; Rita M Hickey; Pauline M Rudd
Journal:  Glycobiology       Date:  2011-05-12       Impact factor: 4.313

Review 5.  Human milk oligosaccharides: every baby needs a sugar mama.

Authors:  Lars Bode
Journal:  Glycobiology       Date:  2012-04-18       Impact factor: 4.313

6.  High levels of growth factors in human breast milk.

Authors:  Ritsuyo Kobata; Hirokazu Tsukahara; Yusei Ohshima; Naoko Ohta; Shuko Tokuriki; Satoshi Tamura; Mitsufumi Mayumi
Journal:  Early Hum Dev       Date:  2007-08-22       Impact factor: 2.079

7.  New chromatographic system for the rapid analysis and preparation of colostrum sialyloligosaccharides.

Authors:  R W Veh; J C Michalski; A P Corfield; M Sander-Wewer; D Gies; R Schauer
Journal:  J Chromatogr       Date:  1981-08-07

8.  Pre-clinical safety evaluation of the synthetic human milk, nature-identical, oligosaccharide 2'-O-Fucosyllactose (2'FL).

Authors:  Myriam Coulet; Phoukham Phothirath; Linda Allais; Benoit Schilter
Journal:  Regul Toxicol Pharmacol       Date:  2013-11-18       Impact factor: 3.271

9.  Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection.

Authors:  Guillermo M Ruiz-Palacios; Luz Elena Cervantes; Pilar Ramos; Bibiana Chavez-Munguia; David S Newburg
Journal:  J Biol Chem       Date:  2003-01-31       Impact factor: 5.157

10.  Intranasal breast milk for premature infants with severe intraventricular hemorrhage-an observation.

Authors:  Titus Keller; Friederike Körber; André Oberthuer; Leonie Schafmeyer; Katrin Mehler; Kathrin Kuhr; Angela Kribs
Journal:  Eur J Pediatr       Date:  2018-11-01       Impact factor: 3.183

View more
  2 in total

1.  Old but Still Hot Target, Glutamate-Mediated Neurotoxicity in Stroke.

Authors:  Hidenori Suzuki; Fumihiro Kawakita; Reona Asada; Fumi Nakano; Hirofumi Nishikawa; Masashi Fujimoto
Journal:  Transl Stroke Res       Date:  2021-10-28       Impact factor: 6.829

Review 2.  In Love with Shaping You-Influential Factors on the Breast Milk Content of Human Milk Oligosaccharides and Their Decisive Roles for Neonatal Development.

Authors:  Christian Hundshammer; Oliver Minge
Journal:  Nutrients       Date:  2020-11-20       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.